Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited.

ABSTRACT:

SUBMITTER: Denis MG 

PROVIDER: S-EPMC9989810 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature